ExploreDaily DealsShop with an ExpertBuy AgainOrdersHelp & Support
Join NowHealthcare provider? Join Now
logoImage
Log In
  • Medical Supplies
  • Pharmacy
  • IV Therapy
About Us
What Makes Us Different?
Who We Are
Our Core Values
Our Testimonials
Our Culture
How Reliable Are We?
Who We Serve
Providing Cutting Edge Solution Globally
Partner With USA MedPremium
Healthcare Professional Statement
Newsroom
Quality Assurance
Our Service & Solutions
Shop with an Expert
Analytics & Reporting
Inventory Management
Distribution Solutions
Streamline Integration
Cost Effective Healthcare solutions
Supply Chain Optimization
Credit Allocation
Customer Service
Live Chat Support
Contact Us
Shipping & Returns
Terms & Conditions
Order Status
Account
Log In
Forgot Password
Healthcare Provider? Join Now
USA MedPremium
LegitScript Certified
LegitScript CertifiedVerified Healthcare Distributor
Follow us:
©2026 USA MedPremium. All rights reserved.
Privacy
Your Privacy Choices
Cookies Preference
Terms of Use
Site Map
Pharmaceutical Licensing
PrivacyPrivacy
Your Privacy ChoicesYour Privacy Choices
Cookies PreferenceCookies Preference
Terms of UseTerms of Use
Site MapSite Map
Pharmaceutical LicensingPharmaceutical Licensing
  1. Home
  2. All Products
  3. Categories
  4. Rx Prescriptions
  5. Immunosuppressive Agents
  6. Immunosuppressive Agent

Benlysta® Belimumab 120 mg Injection for SLE and Lupus Nephritis

USAMP#78015276SKU: 49401010101Benlysta®
rxLicense

License Required

productImage

Product Spotlight

  • Benlysta® is a targeted B-lymphocyte stimulator (BLyS)-specific inhibitor, designed for the management of systemic lupus erythematosus (SLE) in patients aged 5 years and above with active, autoantibody-positive disease, alongside standard therapy.
  • It is also approved for adult patients suffering from active lupus nephritis as part of their comprehensive treatment plan.
  • Benlysta® (belimumab) is presented as a 120 mg/5 mL single-use vial, ensuring a sterile, preservative-free administration for immune system modulation.
  • As an immunosuppressive agent, it plays a crucial role in controlling the progression of lupus by specifically inhibiting the BLyS protein, which is implicated in the disease's pathogenesis.